LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway

Ang Gao(Nankai University), Zhengmao Zhu(Nankai University)
Nature Communications
October 3, 2018
Cited by 73


Related Papers